Robert Guillemette

Robert Guillemette is currently serving as the Associate Director of Regulatory Affairs at ONO PHARMA USA since October 2024. Previously, Robert held the position of Senior Manager of Regulatory Affairs at AVEO Oncology from February 2020 to October 2024 and worked as a Regulatory Affairs Manager at Boston Biomedical, Inc. from June 2019 to February 2020. Additional experience includes roles such as Consultant II at Halloran Consulting Group, Inc., Senior Project Manager at bluebird bio, and various regulatory positions at Agios Pharmaceuticals, Berg LLC, Ocular Therapeutix, Inc., and Merrimack. Robert began the career in regulatory affairs with a position as an eSubmission Publishing and Submission Process Specialist at Millennium Pharmaceuticals. Academic qualifications include a B.A. in Biology from Saint Anselm College, a BS in Design Studies-Architectural Technologies from Boston Architectural College, and a summer program in Psychology at Harvard University.